Mike Regnier

Dr.  Michael Regnier is Washington Research Foundation Endowed Professor and Vice-Chair for Research in the Department of Bioengineering at the University of Washington (UW). He is an Adjunct Professor of Physiology and Biophysics at UW and an Affiliate Investigator of the Benaroya Research Institute in Seattle, WA. Dr. Regnier received his Ph.D. in Neurobiology from the University of Southern California, followed by post-doctoral fellowships studying striated muscle physiology at the Mayo Clinic and UCLA. He is an Established Investigator of the American Heart Association and serves on Scientific Boards of several organizations.  He has also been the director of the Bioengineering Cardiovascular Training Grant (BCTG) for 15+ years.

The Regnier laboratory studies heart and skeletal muscle function and dysfunction with disease.  A big part of his group’s effort is to develop novel gene-, engineered protein- and cell-based therapeutic strategies to treat heart failure and skeletal muscle diseases.  Studies assess the structure and function of muscle at multiple scales from isolated proteins to filaments to cells and tissue and at the whole organ level. His group uses interdisciplinary approaches, including protein engineering, protein biochemical kinetics, proteomic analysis, a variety of contractile mechanics measurement apparatus, viral gene transfer, stem cell derived cardiomyocytes and animal models of injury and disease. A hallmark of his research and training efforts is collaboration with many basic and translational scientists and clinician investigators at the UW and other US institutions, as well as groups in Canada, Italy, England and Germany.